Drug Detail:Lonapegsomatropin (Lonapegsomatropin [ loe-na-peg-soe-ma-troe-pin ])
Drug Class: Growth hormones
Lonapegsomatropin Levels and Effects while Breastfeeding
Summary of Use during Lactation
Lonapegsomatropin is a long-acting prodrug of somatropin, which has been used safely in nursing mothers. The PEG component it is not likely to be enter breastmilk or reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Lonapegsomatropin is not contraindicated in nursing mothers.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date. However, somatropin has been reported to increase milk production.
Alternate Drugs to Consider
Somatropin
Substance Identification
Substance Name
Lonapegsomatropin
CAS Registry Number
1934255-39-6
Drug Class
Breast Feeding
Lactation
Human Growth Hormone
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification